Catarzi, D.; Varano, F.; Vigiani, E.; Calenda, S.; Melani, F.; Varani, K.; Vincenzi, F.; Pasquini, S.; Mennini, N.; Nerli, G.;
et al. 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals 2022, 15, 478.
https://doi.org/10.3390/ph15040478
AMA Style
Catarzi D, Varano F, Vigiani E, Calenda S, Melani F, Varani K, Vincenzi F, Pasquini S, Mennini N, Nerli G,
et al. 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals. 2022; 15(4):478.
https://doi.org/10.3390/ph15040478
Chicago/Turabian Style
Catarzi, Daniela, Flavia Varano, Erica Vigiani, Sara Calenda, Fabrizio Melani, Katia Varani, Fabrizio Vincenzi, Silvia Pasquini, Natascia Mennini, Giulia Nerli,
and et al. 2022. "4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives" Pharmaceuticals 15, no. 4: 478.
https://doi.org/10.3390/ph15040478
APA Style
Catarzi, D., Varano, F., Vigiani, E., Calenda, S., Melani, F., Varani, K., Vincenzi, F., Pasquini, S., Mennini, N., Nerli, G., Dal Ben, D., Volpini, R., & Colotta, V.
(2022). 4-Heteroaryl Substituted Amino-3,5-Dicyanopyridines as New Adenosine Receptor Ligands: Novel Insights on Structure-Activity Relationships and Perspectives. Pharmaceuticals, 15(4), 478.
https://doi.org/10.3390/ph15040478
